Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

The Effect of Pregnancy on Disease Activity in Patients with Psoriatic Arthritis.

Berman M, Zisman D, Wollman J, Levartovsky D, Rimon E, Elkayam O, Paran D.

J Rheumatol. 2018 Dec;45(12):1651-1655. doi: 10.3899/jrheum.171218. Epub 2018 Sep 15.

PMID:
30219770
2.

Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?

Aloush V, Dotan I, Ablin JN, Elkayam O.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):32-36. Epub 2018 Jun 25.

PMID:
29998822
3.

Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients.

Furer V, Hazan E, Mor A, Segal M, Katav A, Aloush V, Elkayam O, George J, Ablin JN.

Pain Res Manag. 2018 May 13;2018:7257681. doi: 10.1155/2018/7257681. eCollection 2018.

4.

Heparanase is expressed in adult human osteoarthritic cartilage and drives catabolic responses in primary chondrocytes.

Gibor G, Ilan N, Journo S, Sharabi A, Dreyer J, Gertel S, Singh P, Menachem A, Snir N, Elkayam O, Vlodavsky I, Arad U.

Osteoarthritis Cartilage. 2018 Aug;26(8):1110-1117. doi: 10.1016/j.joca.2018.05.013. Epub 2018 May 24.

PMID:
29803826
5.

The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.

Sthoeger Z, Sharabi A, Asher I, Zinger H, Segal R, Shearer G, Elkayam O, Mozes E.

Clin Immunol. 2018 Jul;192:85-91. doi: 10.1016/j.clim.2018.05.001. Epub 2018 May 4.

PMID:
29730433
6.

Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.

Danino O, Svetitsky S, Kenigsberg S, Levin A, Journo S, Gold A, Drexler M, Snir N, Elkayam O, Fischer B, Arad U.

Rheumatology (Oxford). 2018 Aug 1;57(8):1472-1480. doi: 10.1093/rheumatology/key092.

PMID:
29688536
7.

Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatment.

Paran D, Smith Y, Pundak S, Arad U, Levartovsky D, Kaufman I, Wollman J, Furer V, Broyde A, Elalouf O, Caspi D, Pel S, Elkayam O.

Curr Med Res Opin. 2018 Oct;34(10):1777-1783. doi: 10.1080/03007995.2018.1443581. Epub 2018 Mar 23.

PMID:
29569514
8.

Sputum Anticitrullinated Protein Antibodies in Patients With Long-standing Rheumatoid Arthritis.

Polachek A, Vree Egberts W, Fireman E, Druckman I, Stark M, Paran D, Kaufman I, Wigler I, Levartovsky D, Caspi D, Pruijn GJM, Elkayam O.

J Clin Rheumatol. 2018 Apr;24(3):122-126. doi: 10.1097/RHU.0000000000000619.

PMID:
29200020
9.
10.

[PRECLINICAL RHEUMATOID ARTHRITIS].

Elalouf O, Elkayam O.

Harefuah. 2017 Jul;156(7):451-454. Review. Hebrew.

PMID:
28786276
11.

Rituximab as a Second-Line Treatment for Lymphocytic Vasculitis of the Central Nervous System.

Anis S, Sharabi A, Mina Y, Klein A, Cagnano E, Elkayam O, Gurevich T.

Isr Med Assoc J. 2016 Oct;18(10):630-632. No abstract available.

12.

Magnetic resonance imaging in diffuse idiopathic skeletal hyperostosis: similarities to axial spondyloarthritis.

Arad U, Elkayam O, Eshed I.

Clin Rheumatol. 2017 Jul;36(7):1545-1549. doi: 10.1007/s10067-017-3617-6. Epub 2017 Mar 31.

PMID:
28364275
13.

Authors' reply.

Furer V, Zisman D, Pokroy-Shapira E, Molad Y, Elkayam O, Paran D.

Scand J Rheumatol. 2017 May;46(3):251-252. doi: 10.1080/03009742.2016.1264628. Epub 2017 Feb 16. No abstract available.

PMID:
28276956
14.

Self-Reported Childhood Maltreatment and Traumatic Events among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis.

Hellou R, Häuser W, Brenner I, Buskila D, Jacob G, Elkayam O, Aloush V, Ablin JN.

Pain Res Manag. 2017;2017:3865249. doi: 10.1155/2017/3865249. Epub 2017 Jan 11.

15.

Cocaine-Induced Vasculitis.

Berman M, Paran D, Elkayam O.

Rambam Maimonides Med J. 2016 Oct 31;7(4). doi: 10.5041/RMMJ.10263. Review.

16.

Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.

Shulman S, Wollman J, Brikman S, Padova H, Elkayam O, Paran D.

Lupus. 2017 Mar;26(3):277-281. doi: 10.1177/0961203316660204. Epub 2016 Jul 21.

PMID:
27440459
17.

Prevalence of Axial Spondyloarthritis Among Patients With Fibromyalgia: A Magnetic Resonance Imaging Study With Application of the Assessment of SpondyloArthritis International Society Classification Criteria.

Ablin JN, Eshed I, Berman M, Aloush V, Wigler I, Caspi D, Likhter M, Wollman J, Paran D, Anouk M, Elkayam O.

Arthritis Care Res (Hoboken). 2017 May;69(5):724-729. doi: 10.1002/acr.22967.

18.

Induced Sputum Analysis in Subjects With Systemic Sclerosis.

Litinsky I, Fireman E, Paran D, Polachek A, Broide A, Sharabi A, Anouk M, Elkayam O.

Respir Care. 2016 Oct;61(10):1369-73. doi: 10.4187/respcare.04706. Epub 2016 Jun 7.

19.

The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study.

Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A, Elalouf O, Sharabi A, Kaufman I, Paran D, Elkayam O.

J Rheumatol. 2016 Sep;43(9):1749-54. doi: 10.3899/jrheum.151491. Epub 2016 Jun 1. Erratum in: J Rheumatol. 2019 Jan;46(1):119.

PMID:
27252430
20.

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1).

Strand V, Mease P, Gossec L, Elkayam O, van den Bosch F, Zuazo J, Pricop L, Mpofu S; FUTURE 1 study group.

Ann Rheum Dis. 2017 Jan;76(1):203-207. doi: 10.1136/annrheumdis-2015-209055. Epub 2016 May 11.

PMID:
27169431
21.

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.

Ablin JN, Elkayam O, Fitzcharles MA.

Rambam Maimonides Med J. 2016 Apr 19;7(2). doi: 10.5041/RMMJ.10239.

22.

Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in Behçet's Disease.

Schwartz R, Borok S, Goldstein M, Kesler A, Regev K, Elkayam O, Habot-Wilner Z.

Case Rep Ophthalmol. 2016 Mar 9;7(1):141-7. doi: 10.1159/000444214. eCollection 2016 Jan-Apr.

23.

Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases.

Broyde A, Arad U, Madar-Balakirski N, Paran D, Kaufman I, Levartovsky D, Wigler I, Caspi D, Elkayam O.

J Rheumatol. 2016 Feb;43(2):267-72. doi: 10.3899/jrheum.150397. Epub 2016 Jan 15.

PMID:
26773117
24.

Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis.

Elalouf O, Elkayam O.

Ther Clin Risk Manag. 2015 Nov 19;11:1719-26. doi: 10.2147/TCRM.S55928. eCollection 2015. Review.

25.

Systemic lupus erythematosus exacerbation following cessation of belimumab treatment.

Furer V, Zisman D, Pokroy-Shapira E, Molad Y, Elkayam O, Paran D.

Scand J Rheumatol. 2016;45(2):103-6. doi: 10.3109/03009742.2015.1074277. Epub 2015 Oct 29.

PMID:
26515057
26.

Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome.

Ablin JN, Aloush V, Brill A, Berman M, Barzilai M, Caspi D, Mandelboim M, Levartovsky D, Polachek A, Wolman Y, Paran D, Barkagan M, Elkayam O.

Reumatismo. 2015 Sep 16;67(2):57-61. doi: 10.4081/reumatismo.2015.823.

27.

Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis.

Polachek A, Korobko U, Mader-Balakirski N, Arad U, Levartovsky D, Kaufman I, Anouk M, Litinsky I, Wigler I, Mendelson E, Paran D, Matz H, Caspi D, Mandelboim M, Elkayam O.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):181-6. Epub 2015 Feb 18.

PMID:
25738420
28.

Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts.

Arad U, Madar-Balakirski N, Angel-Korman A, Amir S, Tzadok S, Segal O, Menachem A, Gold A, Elkayam O, Caspi D.

Cytokine. 2015 May;73(1):30-5. doi: 10.1016/j.cyto.2015.01.016. Epub 2015 Feb 14.

PMID:
25689620
29.

Decreased diffusion capacity on lung function testing in asymptomatic patients with systemic lupus erythematosus does not predict future lung disease.

Elalouf O, Fireman E, Levartovsky D, Kaufman I, Rogovski O, Elkayam O, Caspi D, Paran D.

Lupus. 2015 Aug;24(9):973-9. doi: 10.1177/0961203314566633. Epub 2015 Jan 16.

PMID:
25595620
30.

The fine line between Takayasu arteritis and giant cell arteritis.

Polachek A, Pauzner R, Levartovsky D, Rosen G, Nesher G, Breuer G, Anouk M, Arad U, Sarvagyl-Maman H, Kaufman I, Caspi D, Elkayam O.

Clin Rheumatol. 2015 Apr;34(4):721-7. doi: 10.1007/s10067-014-2813-x. Epub 2014 Nov 23.

PMID:
25416136
31.

Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis.

Zisapel M, Zisman D, Madar-Balakirski N, Arad U, Padova H, Matz H, Maman-Sarvagyl H, Kaufman I, Paran D, Feld J, Litinsky I, Wigler I, Caspi D, Elkayam O.

J Rheumatol. 2015 Jan;42(1):73-8. doi: 10.3899/jrheum.140685. Epub 2014 Nov 15.

PMID:
25399390
32.

Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis.

Orbai AM, Weitz J, Siegel EL, Siebert S, Savage LJ, Aydin SZ, Luime JJ, Elkayam O, Neerinckx B, Urbancek S, de Vlam K, Ritchlin CT; GRAPPA Enthesitis Working Group.

J Rheumatol. 2014 Nov;41(11):2290-4. doi: 10.3899/jrheum.140878. Review.

PMID:
25362713
33.
34.

Ultrasound assessment of enthesis thickening in psoriatic arthritis patients treated with adalimumab compared to methotrexate.

Litinsky I, Balbir-Gurman A, Wollman J, Arad U, Paran D, Caspi D, Elkayam O.

Clin Rheumatol. 2016 Feb;35(2):363-70. doi: 10.1007/s10067-014-2753-5. Epub 2014 Jul 31.

PMID:
25073614
35.

An intensive family intervention clinic for reducing childhood obesity.

Endevelt R, Elkayam O, Cohen R, Peled R, Tal-Pony L, Michaelis Grunwald R, Valinsky L, Porath A, Heymann AD.

J Am Board Fam Med. 2014 May-Jun;27(3):321-8. doi: 10.3122/jabfm.2014.03.130243.

36.

[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].

Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, Mevorach D, Mader R, Sachar T, Amital D, Buskila D; Israeli Rheumatology Association.

Harefuah. 2013 Dec;152(12):742-7, 751, 750. Hebrew.

PMID:
24483001
37.

Tocilizumab in adult-onset Still's disease: the Israeli experience.

Elkayam O, Jiries N, Dranitzki Z, Kivity S, Lidar M, Levy O, Ablin J, Abu-Shakra M, Savargyl-Maman H, Padova H, Caspi D, Rosner I.

J Rheumatol. 2014 Feb;41(2):244-7. doi: 10.3899/jrheum.130881. Epub 2014 Jan 15.

PMID:
24429168
38.

Granulomatosis and polyangiitis: the rituximab option.

Polachek A, Caspi D, Elkayam O.

Isr Med Assoc J. 2013 Mar;15(3):193-4. No abstract available.

39.

Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ).

Ablin JN, Oren A, Cohen S, Aloush V, Buskila D, Elkayam O, Wollman Y, Berman M.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):39-43. Epub 2012 Dec 14.

PMID:
23191939
40.

The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis.

Elkayam O, Bendayan D, Segal R, Shapira Y, Gilburd B, Reuter S, Agmon-Levin N, Shoenfeld Y.

Rheumatol Int. 2013 Apr;33(4):949-53. doi: 10.1007/s00296-012-2487-0. Epub 2012 Aug 4.

PMID:
23011089
41.

Biologic registries in rheumatology: lessons learned and expectations for the future.

Elkayam O, Pavelka K.

Autoimmun Rev. 2012 Dec;12(2):329-36. doi: 10.1016/j.autrev.2012.05.009. Epub 2012 Jun 7. Review.

PMID:
22683382
42.
43.

The perioperative use of biologic agents in patients with rheumatoid arthritis.

Polachek A, Caspi D, Elkayam O.

Autoimmun Rev. 2012 Dec;12(2):164-8. doi: 10.1016/j.autrev.2012.04.001. Epub 2012 Apr 12. Review.

PMID:
22522087
44.

Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controls.

Ablin JN, Aronov N, Shimon I, Kanety H, Pariente C, Aloush V, Elkayam O, Levartovsky D.

Pain Res Manag. 2012 Mar-Apr;17(2):89-92.

45.

Vaccination against influenza in patients with systemic sclerosis.

Litinsky I, Balbir A, Zisman D, Mandelboim M, Mendelson E, Feld J, Braun Y, Anouk M, Kaufman I, Paran D, Caspi D, Elkayam O.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S7-11. Epub 2012 May 29.

PMID:
22409886
46.

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.

Elkayam O, Amir S, Mendelson E, Schwaber M, Grotto I, Wollman J, Arad U, Brill A, Paran D, Levartovsky D, Wigler I, Caspi D, Mandelboim M.

Arthritis Care Res (Hoboken). 2011 Jul;63(7):1062-7. doi: 10.1002/acr.20465.

47.

Anti-neutrophil antibody associated vasculitis in systemic sclerosis.

Arad U, Balbir-Gurman A, Doenyas-Barak K, Amit-Vazina M, Caspi D, Elkayam O.

Semin Arthritis Rheum. 2011 Oct;41(2):223-9. doi: 10.1016/j.semarthrit.2010.11.001. Epub 2011 Feb 1. Review.

PMID:
21277620
48.

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.

Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.

Vaccine. 2011 Feb 11;29(8):1643-8. doi: 10.1016/j.vaccine.2010.12.072. Epub 2011 Jan 4.

PMID:
21211590
49.

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20. Review.

PMID:
21182987
50.

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3.

PMID:
21131643

Supplemental Content

Loading ...
Support Center